caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1972541910

Robert MarksM.D.

GastroenterologyAlabaster, ALI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Robert Marks's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 45 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BAPTIST HEALTH SYSTEM, INC337984
Laboratory Corporation Of America Holdings
Clinical Laboratory · Birmingham, AL
265641
BRAWNER, STEPHEN112337
NPI 126543746199278
MCDANIEL, BENJAMIN87244
Robert Loudon
Gastroenterology · Alabaster, AL
82154
Bradley Rubery
Gastroenterology · Alabaster, AL
81168
Deborah Hayes
Certified Registered Nurse Anesthetist (CRNA) · Birmingham, AL
6099
Gregory Champion
Gastroenterology · Birmingham, AL
5282
Anne Deatkine
Diagnostic Radiology · Alabaster, AL
48109
LAKANEN, KAREN4572
Regional Paramedical Services Inc
Ambulance Service Provider · Jasper, AL
3697
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
506
Unique beneficiaries
—
Total services
705
Distinct HCPCS
13
Medicare payment
$53K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 163 Gastroenterology providers in AL — above median (cohort median 808).
PRESCRIBING · PART D · 2024
Total Rx claims
3,577
Beneficiaries
—
Total drug cost
$753K
Distinct drugs
27
Brand share
32.4%
Top prescribed drugs
Pantoprazole Sodium1,312 claims
Dexlansoprazole470 claims
Linaclotide276 claims
Dicyclomine Hcl243 claims
Famotidine214 claims
QUALITY · MIPS · 2024
Final MIPS score
81.6
Quality
61.9
Cost
79.3
Improvement activities
40.0
Promoting interop.
97.0
Payment adjustment
0.28%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
100
By payment type
Food and Beverage$2K